Wanner C - Search Results

1

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD.

Ramspek CL, Evans M, Wanner C, Drechsler C, Chesnaye NC, Szymczak M, Krajewska M, Torino C, Porto G, Hayward S, Caskey F, Dekker FW, Jager KJ, van Diepen M; EQUAL Study Investigators. Ramspek CL, et al. Among authors: wanner c. J Am Soc Nephrol. 2021 May 3;32(5):1174-1186. doi: 10.1681/ASN.2020071077. Epub 2021 Mar 8. J Am Soc Nephrol. 2021. PMID: 33685974 Free PMC article.

2

Inflammation and cardiovascular risk in dialysis patients.

Wanner C, Zimmermann J, Schwedler S, Metzger T. Wanner C, et al. Kidney Int Suppl. 2002 May;(80):99-102. doi: 10.1046/j.1523-1755.61.s80.18.x. Kidney Int Suppl. 2002. PMID: 11982822 Free article.

3

Advanced glycation end products and mortality in hemodialysis patients.

Schwedler SB, Metzger T, Schinzel R, Wanner C. Schwedler SB, et al. Among authors: wanner c. Kidney Int. 2002 Jul;62(1):301-10. doi: 10.1046/j.1523-1755.2002.00423.x. Kidney Int. 2002. PMID: 12081592 Free article.

4

Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.

Schwedler SB, Guderian F, Dämmrich J, Potempa LA, Wanner C. Schwedler SB, et al. Among authors: wanner c. Nephrol Dial Transplant. 2003 Nov;18(11):2300-7. doi: 10.1093/ndt/gfg407. Nephrol Dial Transplant. 2003. PMID: 14551357

5

Beta(2)-microglobulin removal by extracorporeal renal replacement therapies.

Krieter DH, Lemke HD, Canaud B, Wanner C. Krieter DH, et al. Among authors: wanner c. Biochim Biophys Acta. 2005 Nov 10;1753(1):146-53. doi: 10.1016/j.bbapap.2005.08.008. Epub 2005 Aug 26. Biochim Biophys Acta. 2005. PMID: 16154809 Review.

6

Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.

Krieter DH, Lemke HD, Wanner C. Krieter DH, et al. Among authors: wanner c. Nephrol Dial Transplant. 2006 Feb;21(2):546; author reply 546. doi: 10.1093/ndt/gfi222. Epub 2005 Oct 25. Nephrol Dial Transplant. 2006. PMID: 16249195 No abstract available.

7

C-reactive protein: a family of proteins to regulate cardiovascular function.

Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA. Schwedler SB, et al. Among authors: wanner c. Am J Kidney Dis. 2006 Feb;47(2):212-22. doi: 10.1053/j.ajkd.2005.10.028. Am J Kidney Dis. 2006. PMID: 16431250 Review.

8

Should we reconsider the advanced glycation end product issue in hemodialysis patients?

Schwedler SB, Wanner C. Schwedler SB, et al. Among authors: wanner c. Am J Kidney Dis. 2006 May;47(5):923; author reply 923-4. doi: 10.1053/j.ajkd.2006.02.186. Am J Kidney Dis. 2006. PMID: 16632035 No abstract available.

9

Dyslipidemia, inflammation and dialysis outcomes: what we know now.

Krane V, Drechsler C, Wanner C. Krane V, et al. Among authors: wanner c. Curr Opin Nephrol Hypertens. 2006 Nov;15(6):566-70. doi: 10.1097/01.mnh.0000247501.41420.dd. Curr Opin Nephrol Hypertens. 2006. PMID: 17053468 Review.

10

Lipid metabolism in chronic kidney disease: the role of statins in cardiovascular risk.

Wanner C, Drechsler C, Krane V. Wanner C, et al. J Ren Nutr. 2007 Jan;17(1):75-8. doi: 10.1053/j.jrn.2006.10.012. J Ren Nutr. 2007. PMID: 17198938 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,009 results

Search Page